Eye diseases are difficult to treat due to natural factors such as the blood-eye barrier, cornea or tear film. Polymer-based nanoparticles made of chitosan, among others, can help there to improve drug transport. In this article we would like to summarize a review on this topic.

Berlin, Halle, 16.03.2023: Since January of this year, the project "Zielwirk" is developing a new chitosan technology for the efficient release of mRNA active ingredients. The technology aims to ensure that drugs for the treatment of serious diseases can be better absorbed as well as processed by the body. The participating project partners Heppe Medical Chitosan GmbH, FDX Fluid Dynamix GmbH, Martin Luther University Halle-Wittenberg and the Fraunhofer Institute for Production Systems and Design Technology (IPK) are funded by the German Federal Ministry of Economics and Climate Protection (BMWK) with six million euros over three years.

We are very pleased to announce that Katja Richter, CEO of Heppe Medical Chitosan GmbH, has been appointed to the scientific committee of EUCHIS 2023. EUCHIS 2023, the International Conference of the European Chitin Society (EUCHIS 2023) and the 15th International Conference on Chitin and Chitosan (15th ICCC) will be held in Siglufjörður, Iceland, from September 11-14, 2023.

From 15.02. to 18.02.2023 the ESAO Winterschool 2023 will take place in Lutherstadt Wittenberg. The Winterschool is organized by the Fraunhofer Institute for Microstructure of Materials and Systems (IMWS) and the Martin Luther University Halle-Wittenberg. Next to experts from the academic world, we, Heppe Medical Chitosan GmbH, will also be represented.